- Home
- SIGI vs ALKS Comparison
SIGI vs ALKS Comparison
Compare SIGI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGI
- ALKS
- Stock Information
- Founded
- SIGI 1926
- ALKS 1987
- Country
- SIGI United States
- ALKS Ireland
- Employees
- SIGI N/A
- ALKS N/A
- Industry
- SIGI Property-Casualty Insurers
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SIGI Finance
- ALKS Health Care
- Exchange
- SIGI Nasdaq
- ALKS Nasdaq
- Market Cap
- SIGI 5.5B
- ALKS 5.1B
- IPO Year
- SIGI N/A
- ALKS 1991
- Fundamental
- Price
- SIGI $77.60
- ALKS $26.54
- Analyst Decision
- SIGI Hold
- ALKS Strong Buy
- Analyst Count
- SIGI 7
- ALKS 13
- Target Price
- SIGI $87.33
- ALKS $40.38
- AVG Volume (30 Days)
- SIGI 781.0K
- ALKS 2.1M
- Earning Date
- SIGI 07-23-2025
- ALKS 07-29-2025
- Dividend Yield
- SIGI 1.94%
- ALKS N/A
- EPS Growth
- SIGI 66.75
- ALKS 21.99
- EPS
- SIGI 6.11
- ALKS 2.08
- Revenue
- SIGI $5,112,631,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- SIGI $5.31
- ALKS N/A
- Revenue Next Year
- SIGI $6.91
- ALKS $3.33
- P/E Ratio
- SIGI $12.79
- ALKS $12.77
- Revenue Growth
- SIGI 12.30
- ALKS N/A
- 52 Week Low
- SIGI $71.75
- ALKS $25.56
- 52 Week High
- SIGI $103.56
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- SIGI 39.56
- ALKS 39.42
- Support Level
- SIGI $77.33
- ALKS $26.07
- Resistance Level
- SIGI $79.07
- ALKS $26.87
- Average True Range (ATR)
- SIGI 2.79
- ALKS 0.80
- MACD
- SIGI -0.26
- ALKS 0.04
- Stochastic Oscillator
- SIGI 29.43
- ALKS 27.80
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.